The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

16 Mar 2020 08:41

RNS Number : 2447G
Dechra Pharmaceuticals PLC
16 March 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Long-Term Incentive Scheme

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

138,687

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

138,687

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

0

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

12,603

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

8,759

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,844

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

101,810

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

25,490

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

76,320

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

65,342

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

30,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

48,849

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

46,493

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Global Save As You Earn Plan 2018

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

0

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

70,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

70,000

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to a ris.

 

Date: 16 March 2020

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

2017 Long Term Incentive Plan

Period of return:

From:

15 September 2019

To:

14 March 2020

Balance of unallotted securities under scheme(s) from previous return:

0

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

175,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

175,000

 

 

     

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFIFSTVIIRLII
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.